title: Integrin adjunct therapy for melanoma.
authors.affiliation: Department of Radiation Oncology, University of Virginia, Charlottesville, VA, USA; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, USA.
authors.forename: Kumari L
authors.initials: KL
authors.lastname: Andarawewa
authors.forename: Konstadinos
authors.initials: K
authors.lastname: Moissoglu
authors.forename: Chang
authors.initials: C
authors.lastname: Sup Lee
authors.forename: Yuta
authors.initials: Y
authors.lastname: Ando
authors.forename: Min
authors.initials: M
authors.lastname: Yu
authors.forename: Prianka
authors.initials: P
authors.lastname: Debnath
authors.forename: John D
authors.initials: JD
authors.lastname: Shannon
authors.forename: Suseela
authors.initials: S
authors.lastname: Sirinivasan
authors.forename: Mark R
authors.initials: MR
authors.lastname: Conaway
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Weber
authors.forename: Martin A
authors.initials: MA
authors.lastname: Schwartz
mesh_terms: D064236:Cartilage Oligomeric Matrix Protein / Q000378:metabolism / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D017024:Chemotherapy, Adjuvant; D005353:Fibronectins / Q000494:pharmacology; D006801:Humans; D016023:Integrins / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D064236:Cartilage Oligomeric Matrix Protein; D005353:Fibronectins; D016023:Integrins